Title: Complications in Medical Aesthetics Collaborative Conference 2024
Format: 8 video sessions, approximately 13 GB total
Overview:
This conference is tailored for clinicians in aesthetic medicine who want to deepen their knowledge of complication-management in practice. It brings together expert-led sessions, panel discussions and up-to-date insights into safer injection techniques, complication recognition and resolution, and emerging technologies in aesthetic treatments.
Key Topics Covered:
Vascular adverse events — how to recognise and manage them early.
Ischaemia and visual disturbance – safe practices, diagnosis and intervention.
Lower face injections – approaches to safer injecting in the lower face region.
Infection – prevention, diagnosis and management in aesthetic practice.
Nodules and inflammatory reactions – recognition and treatment strategies.
Safer injecting – revisiting basic and advanced techniques to minimise risk.
Supportive therapies – adjunctive strategies to improve outcomes.
Q&A / expert panel – interactive session addressing real-world complications and audience questions.
Why Watch:
Gain practical, high-impact knowledge from leading experts in aesthetic complication-management.
Learn from real-cases and peer discussions about challenges and solutions in aesthetics.
Elevate your safety standards and confidence in recognising and intervening in complications.
Valuable for any practicing aesthetic physician who wants to proactively reduce risk and improve outcomes in their treatments.
Important Note:
This programme is delivered asynchronously via video content. It does not include (professional medical education) credits or a formal certificate.
Topics:
Session 1 Vascular Adverse Events.mp4
Session 2 lschaemia and Visual Disturbance.mp4
Session 3 Lower Face An approach to safer injecting.mp4
Session 4 Infection.mp4
Session 5 Nodules and inflammatory reactions.mp4
Session 6 Safer Injecting.mp4
Session 7 Supportive Therapies.mp4
Session 8 Question Time Emma Davies & Gillian Murray.mp4









